Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 100.80
-0.20 (-0.20%)
May 28, 2026, 5:39 PM CET
Pharma Mar Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Pharma Mar stock has a consensus rating of "Buy" and an average price target of €108.89. The average 1-year stock price forecast is 8.03% higher than the current stock price, while the lowest is €75.00 (-25.60%) and the highest is €125.00 (+24.01%).
Price Target: €108.89 (+8.03%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 23, 2026.
Analyst Ratings
The average analyst rating for Pharma Mar stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Initiates €121.00 | Buy | Initiates | €121.00 | +20.04% | Apr 23, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains €90.25 → €120.00 | Buy | Maintains | €90.25 → €120.00 | +19.05% | Mar 27, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.